Both antigen dependent and independent processes are thought to contribute to progressive renal allograft failure through pathways which may inter- relate synergistically. The overall objectives of this proposal are: to define the respective contributions of antigen-dependent and antigen- independent injury processes to chronic rejection and their mechanisms of interaction; to dissect out key factors in the pathogenesis of graft injury using specific inhibitors as probes. Project 1 is built upon the insights gained from our studies of an established rat model of chronic rejection where bilaterally nephrectomized Lewis hosts are sustained for prolonged periods by a single Fisher 344 renal allograft (F344->LEW). In the 2 wks after engraftment, well defined forms of antigen dependent and independent injuries occur which stimulate macrophage (mo) chemotaxis. MO have been implicated as effectors of chronic allograft rejection but may also play a role in antigen independent modes of renal injury. TGFbeta an established mediator of renal fibrosis and a MO product is abundantly expressed in both F344- >LEW and forerunners of antigen-independent injury resulting from nephron loss, also precede chronic injury in allografts. Remarkably, supplying additional nephron mass at the time of transplantation limits compensatory adaptive changes in allograft physiology and prevents progressive injury as effectively as sustained immunosuppression. We conclude that chronic antigen dependent and independent injuries are distinct forms of injury which operate synergistically in part because they utilize closely inter- related mechanisms. Accordingly, we will examine the pathophysiology of chronic rejection by integrating key functional, cellular and molecular changes occurring over time. The experimental results will be correlated to events occurring clinically.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Gasser, Martin; Waaga-Gasser, Ana Maria; Grimm, Michael W et al. (2005) Selectin blockade plus therapy with low-dose sirolimus and cyclosporin a prevent brain death-induced renal allograft dysfunction. Am J Transplant 5:662-70
Lee, Iris; Wang, Liqing; Wells, Andrew D et al. (2005) Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 201:1037-44
Tao, Ran; Wang, Liqing; Han, Rongxiang et al. (2005) Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J Immunol 175:5774-82
Lee, Iris; Wang, Liqing; Wells, Andrew D et al. (2003) Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol 171:6929-35
Sho, Masayuki; Harada, Hiroshi; Rothstein, David M et al. (2003) CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy. Transplantation 75:1142-6
Hancock, Wayne W; Gao, Wei; Shemmeri, Nida et al. (2002) Immunopathogenesis of accelerated allograft rejection in sensitized recipients: humoral and nonhumoral mechanisms. Transplantation 73:1392-7
Yuan, Xueli; Dong, Victor M; Coito, Ana J et al. (2002) A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Transplantation 73:1736-42
Ye, Qunrui; Fraser, Christopher C; Gao, Wei et al. (2002) Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med 195:795-800
Gasser, Martin; Waaga, Ana Maria; Kist-Van Holthe, Joana E et al. (2002) Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol 13:1937-45
Laskowski, Igor A; Pratschke, Johann; Wilhelm, Markus J et al. (2002) Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol 13:519-27

Showing the most recent 10 out of 37 publications